CMC aspect of Oligonucleotide Therapeutics

09:30 - 10:05

  • Introduction: Key CMC aspects of oligonucleotide therapeutics
  • Quality control strategies
  • Developability issues and opportunities






Please note that this will be a remote presentation

Aleksandra Dabkowska, Associate Principal Scientist, AstraZeneca